|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/16 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 31/505 | (2006.01) |
| (11) | Number of the document | 2269577 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10174743.4 |
| Date of filing the European patent application | 2001-04-19 | |
| (97) | Date of publication of the European application | 2011-01-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-16 |
| (46) | Date of publication of the claims translation | 2016-06-27 |
| (30) | Number | Date | Country code |
| 577875 | 2000-05-25 | US |
| (72) |
Ramstack, J. Michael, US
Riley, M. Gary, US
Zale, Stephan E., US
Hotz, Joyce M., US
Johnson, Olufunmi L., US
|
| (73) |
Alkermes Pharma Ireland Limited,
Connaught House 1 Burlington Road, Dublin 4,
IE
Alkermes Controlled Therapeutics, Inc., 852 Winter Street, Waltham MA 02451, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Injekcinės suspensijos, turinčios pagerintas injekuojamas savybes |
| Injectable suspensions having improved injectability properties |
| Payment date | Validity (years) | Amount | |
| 2020-03-31 | 347.00 EUR |